These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19167196)

  • 21. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.
    Dizbay M; Fidan I; Kalkanci A; Sari N; Yalcin B; Kustimur S; Arman D
    Scand J Infect Dis; 2010; 42(2):114-20. PubMed ID: 19883150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004.
    Caggiano G; Iatta R; Laneve A; Manca F; Montagna MT
    Mycoses; 2008 Mar; 51(2):123-8. PubMed ID: 18254748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.
    Roilides E; Farmaki E; Evdoridou J; Dotis J; Hatziioannidis E; Tsivitanidou M; Bibashi E; Filioti I; Sofianou D; Gil-Lamaignere C; Mueller FM; Kremenopoulos G
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):745-50. PubMed ID: 15605181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.
    Playford EG; Nimmo GR; Tilse M; Sorrell TC
    J Hosp Infect; 2010 Sep; 76(1):46-51. PubMed ID: 20382444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungemia in non-HIV-infected patients: a five-year review.
    Anunnatsiri S; Chetchotisakd P; Mootsikapun P
    Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors associated with colonization by Candida spp in neonates hospitalized in a Neonatal Intensive Care Unit in Brazil].
    Borges RM; Soares LR; de Brito CS; de Brito DV; Abdallah VO; Filho PP
    Rev Soc Bras Med Trop; 2009; 42(4):431-5. PubMed ID: 19802481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality.
    Alonso-Valle H; Acha O; García-Palomo JD; Fariñas-Alvarez C; Fernández-Mazarrasa C; Fariñas MC
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):254-7. PubMed ID: 12709840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors.
    Boo TW; O'reilly B; O'leary J; Cryan B
    Mycoses; 2005 Jul; 48(4):251-9. PubMed ID: 15982207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W; Morton A; Eisen DP
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and outcome for nosocomial breakthrough candidaemia.
    Pasqualotto AC; Nedel WL; Machado TS; Severo LC
    J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
    Presterl E; Daxböck F; Graninger W; Willinger B
    Clin Microbiol Infect; 2007 Nov; 13(11):1072-6. PubMed ID: 17725647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candidaemia in an Australian teaching hospital: relationship to central line and TPN use.
    Stratov I; Gottlieb T; Bradbury R; O'Kane GM
    J Infect; 1998 Mar; 36(2):203-7. PubMed ID: 9570655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.
    Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV
    Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida spp. other than Candida albicans: a major cause of fungaemia in a tertiary care centre.
    Shivaprakasha S; Radhakrishnan K; Karim PM
    Indian J Med Microbiol; 2007 Oct; 25(4):405-7. PubMed ID: 18087096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality.
    Weinberger M; Leibovici L; Perez S; Samra Z; Ostfeld I; Levi I; Bash E; Turner D; Goldschmied-Reouven A; Regev-Yochay G; Pitlik SD; Keller N
    J Hosp Infect; 2005 Oct; 61(2):146-54. PubMed ID: 16009456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species.
    Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Spiliopoulou I; Tanaseskou L; Karpetas G; Marangos M; Anastassiou ED; Christofidou M
    Infection; 2017 Oct; 45(5):651-657. PubMed ID: 28756598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata.
    Blot S; Vandewoude K; Hoste E; Poelaert J; Colardyn F
    J Hosp Infect; 2001 Apr; 47(4):308-13. PubMed ID: 11289775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends and outcome of 1121 nosocomial bloodstream infections in intensive care units in a Brazilian hospital, 1999-2003.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Barone AA; Costa SF
    Int J Infect Dis; 2008 Nov; 12(6):e145-6. PubMed ID: 18538606
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors for isolation of fluconazole and echinocandin non-susceptible
    Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Tsiata E; Kolonitsiou F; Nikolopoulou A; Papamichail C; Spiliopoulou I; Marangos M; Christofidou M
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.